Kenvue Inc. Common Stock vs iShares MSCI China ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while iShares MSCI China ETF trades at $52.53 (market cap $5.94B). The key difference: Kenvue Inc. Common Stock is far larger — about 5.7× iShares MSCI China ETF's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while iShares MSCI China ETF pays none. Which is the better fit depends on your goals.
| KVUE | MCHI | |
|---|---|---|
Market Cap | $34.06B | $5.94B |
Volume | 23,267,228 | 1,575,471 |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $19.83 | $65.59 |
52-Week Low | $14.11 | $50.48 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 63 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MCHI trades at $52.55, up 1.76% today, but technical indicators show a bearish trend with moving averages signaling strong selling pressure. The ETF faces headwinds from China's economic challenges including industrial overcapacity and weak domestic consumption. Recent news highlights potential trade tensions ahead of the Trump-Xi summit, though corporate profits surged 26% in Q2 according to Zacks Investment Research (2026-09-08).
The outlook remains cautious due to China's macroeconomic pressures and global trade risks. Investment opportunity exists in MCHI's significant discount to historical valuations versus US indices, but risks include potential export controls and protectionism. The ETF's financial sector benefits from China's steepening yield curve, supporting bank and insurance holdings.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →